Skip to content
Unrated Drug recall · FDA · Published August 24, 2016

Sandoz Phenylephrine Injection Recall: Risk of Contaminated Product

Sandoz recalls phenylephrine injections due to potential sterility issues found during FDA inspection. Products with specific NDC numbers and expiration dates are affected. Consumers should contact Sandoz for details.

🇺🇸 FDA recall #D-1514-2016DrugSandoz ›
Take action

Contact the company

Recalling firmSandoz Inc100 College Rd W · Princeton, NJ 08540-6604
✎ GovInfoNow plain-language explainer

What happened, in plain English

Sandoz is recalling phenylephrine injections that may not be sterile, as found during an FDA inspection. This could lead to infections if the product is used. Affected products have specific NDC numbers and expiration dates. Read more at govinfonow.com/recall/42470-sandoz-phenylephrine-injection-recall-risk-of-contaminated-product.

Source Summary by GovInfoNow · govinfonow.com/recall/42470-sandoz-phenylephrine-injection-recall-risk-of-contaminated-product · Updated October 9, 2026 · FDA enforcement record: FDA #D-1514-2016

Cite this page

“Sandoz Phenylephrine Injection Recall: Risk of Contaminated Product.” GovInfoNow, updated October 9, 2026. https://govinfonow.com/recall/42470-sandoz-phenylephrine-injection-recall-risk-of-contaminated-product. Based on FDA recall #D-1514-2016 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1514-2016%22&limit=1).

Why it’s dangerous

The FDA inspection found concerns that the product might not be sterile. If the injection is not sterile, it could cause infections when used in medical procedures.

Who’s affected

People who have the recalled phenylephrine injections (NDC 66758-016-03 or 66758-017-01) are affected. Those using the product for medical purposes are at risk of infection.

How to tell if you have this one

Check for NDC numbers 66758-016-03 (25 x 5 mL vials) or 66758-017-01 (10 mL vials) with expiration dates listed as 09/16 or 08/16.

  • Brand
    Sandoz
  • Category
    Drug
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Nationwide and Puerto Rico
Recall numberProduct, codes & lotsQuantity
D-1513-2016Ephedrine Sulfate Injection, USP, 50 mg/mL, 1 mL Fill in a 2mL Vial (NDC 66758-008-01), packaged in 25 x 2 mL Vials per carton (NDC 66758-008-02), Rx only, Manufactured for: Sandoz Inc., Princeton, NJ 08540.; Lot #: 080514, 080614, 081114, 081214, 081314, 081414, 082714, 082814, 082914, Exp 08/16; 090214, 090314, 090814, 090914, 091014, 091114, 091214, 091514, Exp 09/1632,099 cartons
D-1514-2016Phenylephrine HCI Injection, USP, 10mg/mL, packaged in a) 5 mL Vial, 50 mg/5 mL (NDC 66758-016-03), 25 x 5 mL Vials per carton (NDC 66758-016-04) and b) 10 mL Vials, 100 mg/10 mL (NDC 66758-017-01), Rx only, Manufactured for: Sandoz Inc., Princeton, NJ 08540.; Lot #: a) 091914, Exp 09/16; b) 080114, Exp 08/16; 090414, 092614, Exp 09/16a) 1,584 cartons; b) 62,170 vials
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for the NDC numbers 66758-016-03 or 66758-017-01 on the packaging.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFLPuerto Rico: yesPR

FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 11 months after the firm started it.

1. Firm started the recall: Aug 24, 201612. FDA classified it Class II: Sep 19, 201623. Published in FDA’s Enforcement Report: Sep 28, 201634. FDA terminated the recall: Jul 12, 2017420162017
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Sandoz recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1514-2016 (August 24, 2016) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1514-2016 to see it in context.
  • Plain-language summary written by qwen3:4b on October 9, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA